All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Asia EquityAsia IPOs

Kintor Pharma sets Hong Kong IPO in motion

pills adobe stock 575x375 pharmaceuticals

China-based Kintor Pharmaceutical has kicked off bookbuilding for its Hong Kong listing, the latest in a stream of healthcare IPOs in the city. The issuer is targeting HK$1.86bn ($240.1m) in proceeds.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.

By continuing to use & browse the site you agree to our Privacy Policy.
I agree